Cargando…
A Review of Precision Oncology Knowledgebases for Determining the Clinical Actionability of Genetic Variants
The increased availability of tumor genetic testing and targeted cancer therapies contributes to the advancement of precision medicine in the field of oncology. Precision oncology knowledgebases provide a way of organizing clinically relevant genetic information in a way that is easily accessible fo...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7026022/ https://www.ncbi.nlm.nih.gov/pubmed/32117976 http://dx.doi.org/10.3389/fcell.2020.00048 |
_version_ | 1783498601752690688 |
---|---|
author | Li, Xuanyi Warner, Jeremy L. |
author_facet | Li, Xuanyi Warner, Jeremy L. |
author_sort | Li, Xuanyi |
collection | PubMed |
description | The increased availability of tumor genetic testing and targeted cancer therapies contributes to the advancement of precision medicine in the field of oncology. Precision oncology knowledgebases provide a way of organizing clinically relevant genetic information in a way that is easily accessible for both oncologists and patients, facilitating the genetic-based clinical decision making. Many organizations and companies have built precision oncology knowledgebases, intended for multiple users. In general, these knowledgebases offer information on cancer-related genetic variants as well as their associated diagnostic, prognostic, and therapeutic implications, but they often differ in their information curations, designs, and user experiences. It is advisable that oncologists use multiple knowledgebases during their practice to have them complement each other. In the future, convergence toward common standards and formats is needed to ensure that the comprehensive knowledge across all sources can be unified to bring the oncology community closer to the achievement of the goal of precision oncology. |
format | Online Article Text |
id | pubmed-7026022 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-70260222020-02-28 A Review of Precision Oncology Knowledgebases for Determining the Clinical Actionability of Genetic Variants Li, Xuanyi Warner, Jeremy L. Front Cell Dev Biol Cell and Developmental Biology The increased availability of tumor genetic testing and targeted cancer therapies contributes to the advancement of precision medicine in the field of oncology. Precision oncology knowledgebases provide a way of organizing clinically relevant genetic information in a way that is easily accessible for both oncologists and patients, facilitating the genetic-based clinical decision making. Many organizations and companies have built precision oncology knowledgebases, intended for multiple users. In general, these knowledgebases offer information on cancer-related genetic variants as well as their associated diagnostic, prognostic, and therapeutic implications, but they often differ in their information curations, designs, and user experiences. It is advisable that oncologists use multiple knowledgebases during their practice to have them complement each other. In the future, convergence toward common standards and formats is needed to ensure that the comprehensive knowledge across all sources can be unified to bring the oncology community closer to the achievement of the goal of precision oncology. Frontiers Media S.A. 2020-02-11 /pmc/articles/PMC7026022/ /pubmed/32117976 http://dx.doi.org/10.3389/fcell.2020.00048 Text en Copyright © 2020 Li and Warner. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cell and Developmental Biology Li, Xuanyi Warner, Jeremy L. A Review of Precision Oncology Knowledgebases for Determining the Clinical Actionability of Genetic Variants |
title | A Review of Precision Oncology Knowledgebases for Determining the Clinical Actionability of Genetic Variants |
title_full | A Review of Precision Oncology Knowledgebases for Determining the Clinical Actionability of Genetic Variants |
title_fullStr | A Review of Precision Oncology Knowledgebases for Determining the Clinical Actionability of Genetic Variants |
title_full_unstemmed | A Review of Precision Oncology Knowledgebases for Determining the Clinical Actionability of Genetic Variants |
title_short | A Review of Precision Oncology Knowledgebases for Determining the Clinical Actionability of Genetic Variants |
title_sort | review of precision oncology knowledgebases for determining the clinical actionability of genetic variants |
topic | Cell and Developmental Biology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7026022/ https://www.ncbi.nlm.nih.gov/pubmed/32117976 http://dx.doi.org/10.3389/fcell.2020.00048 |
work_keys_str_mv | AT lixuanyi areviewofprecisiononcologyknowledgebasesfordeterminingtheclinicalactionabilityofgeneticvariants AT warnerjeremyl areviewofprecisiononcologyknowledgebasesfordeterminingtheclinicalactionabilityofgeneticvariants AT lixuanyi reviewofprecisiononcologyknowledgebasesfordeterminingtheclinicalactionabilityofgeneticvariants AT warnerjeremyl reviewofprecisiononcologyknowledgebasesfordeterminingtheclinicalactionabilityofgeneticvariants |